Healthcare & Life Sciences
Delfi Diagnostics
United Statesdelfidiagnostics.com
Delfi Diagnostics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
Activeseries-a
series-a
Stage
2018
Founded
2
Investors
About Delfi Diagnostics
Based in the United States, Delfi Diagnostics is a startup founded in 2018. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Delfi Diagnostics develops AI-driven liquid biopsy tests that analyze cell-free DNA fragmentation patterns from blood samples to detect lung cancer early and monitor treatment.
Explore Delfi Diagnostics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.